Surgical Science Sweden AB
STO:SUS

Watchlist Manager

Surgical Science Sweden AB

STO:SUS

Watchlist

Price: 122.4 SEK 2.77% Market Closed

Market Cap: 6.2B SEK

Have any thoughts about
Surgical Science Sweden AB?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	Abbvie Inc NYSE:ABBV	Biotechnology
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Realty Income Corp NYSE:O	Real Estate
US	Walt Disney Co NYSE:DIS	Media
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 122.4 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

SUS Alert

Surgical Science Sweden AB

122.4

+3.3 (+2.77%)

52 Week Range	113.7 193.3
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	Abbvie Inc NYSE:ABBV	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Realty Income Corp NYSE:O	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Surgical Science Sweden AB

What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?

What risks and challenges
does Surgical Science Sweden AB face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Surgical Science Sweden AB.

What unique competitive advantages
does Surgical Science Sweden AB hold over its rivals?

What risks and challenges
does Surgical Science Sweden AB face in the near future?

Summarize the latest earnings call
of Surgical Science Sweden AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Surgical Science Sweden AB.

Provide P/S
for Surgical Science Sweden AB.

Provide P/E
for Surgical Science Sweden AB.

Provide P/OCF
for Surgical Science Sweden AB.

Provide P/FCFE
for Surgical Science Sweden AB.

Provide P/B
for Surgical Science Sweden AB.

Provide EV/S
for Surgical Science Sweden AB.

Provide EV/GP
for Surgical Science Sweden AB.

Provide EV/EBITDA
for Surgical Science Sweden AB.

Provide EV/EBIT
for Surgical Science Sweden AB.

Provide EV/OCF
for Surgical Science Sweden AB.

Provide EV/FCFF
for Surgical Science Sweden AB.

Provide EV/IC
for Surgical Science Sweden AB.

Show me price targets
for Surgical Science Sweden AB made by professional analysts.

What are the Revenue projections
for Surgical Science Sweden AB?

How accurate were the past Revenue estimates
for Surgical Science Sweden AB?

What are the Net Income projections
for Surgical Science Sweden AB?

How accurate were the past Net Income estimates
for Surgical Science Sweden AB?

What are the EPS projections
for Surgical Science Sweden AB?

How accurate were the past EPS estimates
for Surgical Science Sweden AB?

What are the EBIT projections
for Surgical Science Sweden AB?

How accurate were the past EBIT estimates
for Surgical Science Sweden AB?

Compare the revenue forecasts
for Surgical Science Sweden AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Surgical Science Sweden AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Surgical Science Sweden AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Surgical Science Sweden AB compared to its peers.

Compare the P/E ratios
of Surgical Science Sweden AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Surgical Science Sweden AB with its peers.

Analyze the financial leverage
of Surgical Science Sweden AB compared to its main competitors.

Show all profitability ratios
for Surgical Science Sweden AB.

Provide ROE
for Surgical Science Sweden AB.

Provide ROA
for Surgical Science Sweden AB.

Provide ROIC
for Surgical Science Sweden AB.

Provide ROCE
for Surgical Science Sweden AB.

Provide Gross Margin
for Surgical Science Sweden AB.

Provide Operating Margin
for Surgical Science Sweden AB.

Provide Net Margin
for Surgical Science Sweden AB.

Provide FCF Margin
for Surgical Science Sweden AB.

Show all solvency ratios
for Surgical Science Sweden AB.

Provide D/E Ratio
for Surgical Science Sweden AB.

Provide D/A Ratio
for Surgical Science Sweden AB.

Provide Interest Coverage Ratio
for Surgical Science Sweden AB.

Provide Altman Z-Score Ratio
for Surgical Science Sweden AB.

Provide Quick Ratio
for Surgical Science Sweden AB.

Provide Current Ratio
for Surgical Science Sweden AB.

Provide Cash Ratio
for Surgical Science Sweden AB.

What is the historical Revenue growth
over the last 5 years for Surgical Science Sweden AB?

What is the historical Net Income growth
over the last 5 years for Surgical Science Sweden AB?

What is the current Free Cash Flow
of Surgical Science Sweden AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Surgical Science Sweden AB.

SUS

Balance Sheet

Additional Paid In Capital

Surgical Science Sweden AB
Additional Paid In Capital

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

Adjust for Inflation

Surgical Science Sweden AB
Additional Paid In Capital Peer Comparison

Comparables:

EKTA B

CEVI

GETI B

ARJO B

ELOS B

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company		Additional Paid In Capital	CAGR 3Y	CAGR 5Y	CAGR 10Y
S	Surgical Science Sweden AB STO:SUS	Additional Paid In Capital kr3.4B	CAGR 3-Years 65%	CAGR 5-Years N/A	CAGR 10-Years N/A
	Elekta AB (publ) STO:EKTA B	Additional Paid In Capital kr812m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	CellaVision AB STO:CEVI	Additional Paid In Capital N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Getinge AB STO:GETI B	Additional Paid In Capital kr6.8B	CAGR 3-Years 0%	CAGR 5-Years 0%	CAGR 10-Years N/A
	Arjo AB (publ) STO:ARJO B	Additional Paid In Capital N/A	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Elos Medtech AB STO:ELOS B	Additional Paid In Capital kr145.5m	CAGR 3-Years 0%	CAGR 5-Years 21%	CAGR 10-Years N/A

What is Surgical Science Sweden AB's Additional Paid In Capital?

Additional Paid In Capital
3.4B SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Additional Paid In Capital amounts to 3.4B SEK.

What is Surgical Science Sweden AB's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 3Y
65%

Over the last year, the Additional Paid In Capital growth was 0%. The average annual Additional Paid In Capital growth rates for Surgical Science Sweden AB have been 65% over the past three years .

Surgical Science Sweden AB
STO:SUS

Surgical Science Sweden AB
Additional Paid In Capital

Surgical Science Sweden AB
Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

See Also

What is Surgical Science Sweden AB's Additional Paid In Capital?

Additional Paid In Capital
3.4B SEK

What is Surgical Science Sweden AB's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 3Y
65%

Company

Help

Tools

Stocks

Surgical Science Sweden AB STO:SUS

Surgical Science Sweden AB Additional Paid In Capital

Surgical Science Sweden AB Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis Latest Figures & CAGR of Competitors

See Also

What is Surgical Science Sweden AB's Additional Paid In Capital? Additional Paid In Capital 3.4B SEK

What is Surgical Science Sweden AB's Additional Paid In Capital growth rate? Additional Paid In Capital CAGR 3Y 65%

Company

Help

Tools

Stocks

Surgical Science Sweden AB
STO:SUS

Surgical Science Sweden AB
Additional Paid In Capital

Surgical Science Sweden AB
Additional Paid In Capital Peer Comparison

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

What is Surgical Science Sweden AB's Additional Paid In Capital?

Additional Paid In Capital
3.4B SEK

What is Surgical Science Sweden AB's Additional Paid In Capital growth rate?

Additional Paid In Capital CAGR 3Y
65%